SCRI Development Innovations, LLC赞助的临床试验
总计198个结果
-
SCRI Development Innovations, LLC终止
-
MorphotekSCRI Development Innovations, LLC完全的
-
SCRI Development Innovations, LLCCelgene终止
-
SCRI Development Innovations, LLCNovartis完全的
-
MedicureSCRI Development Innovations, LLC完全的
-
MedicureSCRI Development Innovations, LLC撤销心肌梗塞 | 经皮冠状动脉介入治疗 | 不稳定型心绞痛 | 急性冠状动脉综合征
-
SCRI Development Innovations, LLCNovartis终止
-
SCRI Development Innovations, LLCGlaxoSmithKline完全的
-
SCRI Development Innovations, LLCBayer完全的
-
SCRI Development Innovations, LLCNovartis完全的
-
SCRI Development Innovations, LLCNovartis完全的
-
SCRI Development Innovations, LLCPfizer完全的
-
SCRI Development Innovations, LLCNovartis撤销
-
SCRI Development Innovations, LLCAmgen完全的
-
SCRI Development Innovations, LLCBayer完全的
-
SCRI Development Innovations, LLCNovartis完全的
-
SCRI Development Innovations, LLCBayer完全的
-
SCRI Development Innovations, LLCNovartis完全的
-
SCRI Development Innovations, LLCAstraZeneca完全的
-
SCRI Development Innovations, LLCBiogen完全的
-
SCRI Development Innovations, LLCNovartis完全的
-
SCRI Development Innovations, LLCBayer完全的
-
SCRI Development Innovations, LLCPfizer完全的
-
SCRI Development Innovations, LLCPfizer撤销
-
SCRI Development Innovations, LLCIpsen终止
-
SCRI Development Innovations, LLCGlaxoSmithKline终止